top of page
Revolutionizing Radiopharmaceutical Development through the Innovative Peptide Discovery Platform CUS™
Founded in 2017, C-Biomex Co., Ltd is a pioneering bio-venture focused on advancing novel theranostics using
its exclusive peptide discovery platform technology.
About Us
Our innovative discovery platform, CUS™, facilitates the identification of peptides with remarkable stability and selectivity through a three-differentiated approach: (1) Crafting a high-purity library using an optimized process,
(2) Employing a novel screening procedure that minimizes background interactions, and
(3) Achieving direct sequencing utilizing our proprietary analyzing algorithm.
Our Technology
Proprietary Peptide Discovery Platform (CUS™)
bottom of page